NEW HAVEN, Conn. (AP) _ Achillion Pharmaceuticals Inc. (ACHN) on Thursday reported a fourth-quarter loss of $4.4 million, after reporting a profit in the same period a year earlier.
The New Haven, Connecticut-based company said it had a loss of 3 cents per share.
The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 18 cents per share.
The biopharmaceutical company posted revenue of $15 million in the period.
For the year, the company reported that its loss widened to $61.7 million, or 45 cents per share. Revenue was reported as $15 million.
Achillion expects a full-year loss of 75 cents to 70 cents per share.
In the final minutes of trading on Thursday, the company's shares hit $4.24. A year ago, they were trading at $6.70.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ACHN at https://www.zacks.com/ap/ACHN
Keywords: Achillion Pharmaceuticals, Earnings Report